Delphyr logo — Delphyr is a medical data platform that unlocks patient-leve...

Delphyr

Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians.

Founded 2023 The Netherlands The Netherlands 11 employees Unknown Total: $2.03M AI, Health Care +1

General Information

Company Name Delphyr
Founded Year 2023
Location The Netherlands The Netherlands +1
Employees 11
Industries AI, Health Care, Healthtech
Funding Stage Unknown
Social

Get notified when Delphyr moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Delphyr recently secured a significant €1.75M Angel round in March 2026, swiftly followed by a substantial 57.49% website update in June 2026. This dynamic shift suggests the company is strategically refining its market communication and potentially unveiling enhanced product capabilities post-funding. The moves indicate an accelerated push for market presence and user acquisition in the healthcare AI sector.

Signal Types
Funding Product Marketing
Strategic Labels
Post-Funding Strategy Brand Refresh Market Positioning
Next Move: Expansion
·
Impact: 8/10
·
Ideal For: Early-Stage Healthtech VCs — Seed

About Delphyr

Delphyr, founded in 2023, is an AI-driven platform poised to revolutionize healthcare analytics. As a pioneer in the AI and Healthtech sectors, the company is based in The Netherlands.

With the slogan, "Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians," the platform is designed to streamline data analytics, optimizing time management for healthcare professionals while enhancing patient outcomes and minimizing hospital expenditures.

Delphyr recently secured a €1.75M angel investment on 01 March 2026, with backing from notable investors such as Gijs Nagel and Thomas Wolf. This funding milestone underscores strong confidence in Delphyr's vision and potential for transformative impact in medical data processing.

The company's cutting-edge technology positions it strategically at the intersection of healthcare and artificial intelligence, making it an attractive opportunity for further investment and growth within these dynamic industries.

Taxonomy: Medical Data Platform, Patient-Level Data Analytics, AI-Driven Technology, Clinical Decision Support, Digital Health, Healthcare Efficiency, Outcome Improvement, Cost Reduction, Machine Learning in Medicine, Advanced Medical Statistics, Surgery Analytics, Anesthesiology Data, Internal Medicine Analytics

Services & Products

AI-powered clinical workflow integration
Automated patient information management
EHR extension and optimization
Summarization of medical data
Compliance with healthcare regulations

Target Customers

Healthcare professionals Hospitals Primary care physicians Mental health clinics General practitioners

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Angel •••••• 2 •••• •••• 01 Mar 2026
Angel •••••• 1
Investor
01 Dec 2024

Delphyr Alternatives & Competitors

View All Alternatives
Delphyr vs

Empowering health journeys with precise patient data.

Series Unknown
1 employees
Health Care
Delphyr vs
Deep Breath 🫁
Deep Breath 🫁 The Netherlands

Better ICU care is here. Just ask the data.

Seed
8 employees
AI, Health Care
Delphyr vs

Empowering Pharmaceutical Brands with Advanced Data Insights for Enhanced Patient Outcomes

Design, Pharmaceutical

FAQ About Delphyr

Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians.
Delphyr was founded in 2023.
Delphyr is headquartered in The Netherlands.
Delphyr operates in the following industries: AI, Health Care, Healthtech.
Delphyr has approximately 11 employees.
Delphyr has completed 2 funding rounds, raising a total of $2.03M. The latest funding stage is Unknown.
Delphyr offers: AI-powered clinical workflow integration, Automated patient information management, EHR extension and optimization, Summarization of medical data, Compliance with healthcare regulations.
Top alternatives and competitors to Delphyr include SensorRx, Deep Breath 🫁, ProMetrics Consulting, moveUP - digital therapies, HippocrAItes. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Delphyr and SensorRx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Delphyr and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy